Why the study?
Platelet aggregation relies on complex intracellular signaling networks triggered by diverse receptors in response to various agonists.
This review provides a comprehensive overview of platelet receptor intracellular signaling pathways and their synergistic interactions.
Synthesizes platelet signaling knowledge; leaves open clinical translation and targeted validation.
Small, non-nuclear cells, platelets, are primarily designed to form aggregates when blood vessels are damaged, stopping bleeding. To perform this function, platelets can implement several functional responses induced by various agonists and coordinated by a complex network of intracellular signaling triggered by a dozen of different receptors. This review, the second in a series, describes the known intracellular signaling pathways induced by platelet receptors in response to canonical and rare agonists. Particular focus will be on interaction points and “synergy” of platelet activation pathways and intermediate or “secondary” activation mediators that transmit a signal to functional manifestations.
No takes yet. Share an insight, caveat, or question.
Martyanov et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: